Anti-adhesion molecule therapies in inflammatory bowel disease: Touch and go

Autoimmunity Reviews

Volumn 7, Issue 5, 2008, Pages 364-369

  Stefanelli, Tommaso ^a   Malesci, Alberto ^a   De La Rue, Sarah A ^a   Danese, Silvio ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Anti 4 7 integrin therapy; Cell adhesion molecules; Crohn's Disease; Ulcerative Colitis

Indexed keywords

ALPHA4 INTEGRIN ANTIBODY; ANTISENSE OLIGONUCLEOTIDE; BETA1A INTERFERON; BETA7 INTEGRIN ANTIBODY; CELL ADHESION MOLECULE; CORTICOSTEROID; DEXAMETHASONE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INTEGRIN; L SELECTIN; MADCAM 1 ANTIBODY; MESALAZINE; MLN 02; NATALIZUMAB; PADGEM PROTEIN; PLACEBO; PROTEIN ANTIBODY;

ABSENCE OF SIDE EFFECTS; CELL SURFACE; CLINICAL TRIAL; COLITIS; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CROHN DISEASE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; ENTERITIS; HUMAN; LEUKOCYTE ADHERENCE; MONOTHERAPY; MULTIPLE SCLEROSIS; NONHUMAN; OPPORTUNISTIC INFECTION; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROTEIN EXPRESSION; PROTEIN FAMILY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SINGLE DRUG DOSE; TREATMENT OUTCOME; TREATMENT RESPONSE; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

ANTIBODIES, MONOCLONAL; CELL ADHESION; HUMANS; INFLAMMATORY BOWEL DISEASES; INTEGRIN ALPHA4; INTEGRINS; SELECTINS;

EID: 43449095992     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2008.01.002     Document Type: Review

References (34)

1. Mori N., Horie Y., Gerritsen M.E., Anderson D.C., and Granger D.N. Anti-inflammatory drugs and endothelial cell adhesion molecule expression in murine vascular beds. Gut 44 (1999) 186-195
2. Berlin C., Berg E.L., Briskin M.J., Andrew D.P., Kilshaw P.J., Holzmann B., et al. Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74 (1993) 185-195
3. Danese S., and Fiocchi C. Etiopathogenesis of inflammatory bowel diseases. World J Gastroenterol 12 (2006) 4807-4812
4. Lang K.S., Burow A., Kurrer M., Lang P.A., and Recher M. The role of the innate immune response in autoimmune disease. J Autoimmun 29 (2007) 206-212
5. Milner J., Ward J., Keane-Myers A., Min B., and Paul W.E. Repertoire-dependent immunopathology. J Autoimmun 29 (2007) 257-261
6. Peng Y., Martin D.A., Kenkel J., Zhang K., Ogden C.A., and Elkon K.B. Innate and adaptive immune response to apoptotic cells. J Autoimmun 29 (2007) 303-309
7. Scaldaferri F., Sans M., Vetrano S., Graziani C., De Cristofaro R., Gerlitz B., et al. Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease. J Clin Invest 117 (2007) 1951-1960
8. Danese S., de la Motte C., Sturm A., Vogel J.D., West G.A., Strong S.A., et al. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology 124 (2003) 1249-1264
9. Hirata T., Merrill-Skoloff G., Aab M., Yang J., Furie B.C., and Furie B. P-Selectin glycoprotein ligand 1 (PSGL-1) is a physiological ligand for E-selectin in mediating T helper 1 lymphocyte migration. J Exp Med 192 (2000) 1669-1676
10. Ley K. The role of selectins in inflammation and disease. Trends Mol Med 9 (2003) 263-268
11. Yoshida M., and Gimbrone Jr. M.A. Novel roles for E-selectin in endothelial-leukocyte adhesion. Ann N Y Acad Sci 811 (1997) 493-497
12. Cambien B., and Wagner D.D. A new role in hemostasis for the adhesion receptor P-selectin. Trends Mol Med 10 (2004) 179-186
13. Khan A.I., Landis R.C., and Malhotra R. L-Selectin ligands in lymphoid tissues and models of inflammation. Inflammation 27 (2003) 265-280
14. Sako D., Chang X.J., Barone K.M., Vachino G., White H.M., Shaw G., et al. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell 75 (1993) 1179-1186
15. Moore K.L., Patel K.D., Bruehl R.E., Li F., Johnson D.A., Lichenstein H.S., et al. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol 128 (1995) 661-671
16. Lasky L.A., Singer M.S., Dowbenko D., Imai Y., Henzel W.J., Grimley C., et al. An endothelial ligand for L-selectin is a novel mucin-like molecule. Cell 69 (1992) 927-938
17. Baumheter S., Singer M.S., Henzel W., Hemmerich S., Renz M., Rosen S.D., et al. Binding of L-selectin to the vascular sialomucin CD34. Science 262 (1993) 436-438
18. Marlin S.D., and Springer T.A. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 51 (1987) 813-819
19. Ben-Horin S., and Bank I. The role of very late antigen-1 in immune-mediated inflammation. Clin Immunol 113 (2004) 119-129
20. Hu M.C., Crowe D.T., Weissman I.L., and Holzmann B. Cloning and expression of mouse integrin beta p(beta 7): a functional role in Peyer's patch-specific lymphocyte homing. Proc Natl Acad Sci U S A 89 (1992) 8254-8258
21. Elices M.J., Osborn L., Takada Y., Crouse C., Luhowskyj S., Hemler M.E., et al. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60 (1990) 577-584
22. Bell R.G., and Issekutz T. Expression of a protective intestinal immune response can be inhibited at three distinct sites by treatment with anti-alpha 4 integrin. J Immunol 151 (1993) 4790-4802
23. Strauch U.G., Lifka A., Gosslar U., Kilshaw P.J., Clements J., and Holzmann B. Distinct binding specificities of integrins alpha 4 beta 7 (LPAM-1), alpha 4 beta 1 (VLA-4), and alpha IEL beta 7. Int Immunol 6 (1994) 263-275
24. Wagner N., Lohler J., Kunkel E.J., Ley K., Leung E., Krissansen G., et al. Critical role for beta7 integrins in formation of the gut-associated lymphoid tissue. Nature 382 (1996) 366-370
25. + T cells. J Immunol 158 (1997) 2099-2106
26. Rivera-Nieves J., Burcin T.L., Olson T.S., Morris M.A., McDuffie M., Cominelli F., et al. Critical role of endothelial P-selectin glycoprotein ligand 1 in chronic murine ileitis. J Exp Med 203 (2006) 907-917
27. Goto A., Arimura Y., Shinomura Y., Imai K., and Hinoda Y. Antisense therapy of MAdCAM-1 for trinitrobenzenesulfonic acid-induced murine colitis. Inflamm Bowel Dis 12 (2006) 758-765
28. Kent S.J., Karlik S.J., Cannon C., Hines D.K., Yednock T.A., Fritz L.C., et al. A monoclonal antibody to alpha 4 integrin suppresses and reverses active experimental allergic encephalomyelitis. J Neuroimmunol 58 (1995) 1-10
29. Gordon F.H., Lai C.W., Hamilton M.I., Allison M.C., Srivastava E.D., Fouweather M.G., et al. A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn's disease. Gastroenterology 121 (2001) 268-274
30. Ghosh S., Goldin E., Gordon F.H., Malchow H.A., Rask-Madsen J., Rutgeerts P., et al. Natalizumab for active Crohn's disease. N Engl J Med 348 (2003) 24-32
31. Sandborn W.J., Colombel J.F., Enns R., Feagan B.G., Hanauer S.B., Lawrance I.C., et al. Natalizumab induction and maintenance therapy for Crohn's disease. N Engl J Med 353 (2005) 1912-1925
32. Gordon F.H., Hamilton M.I., Donoghue S., Greenlees C., Palmer T., Rowley-Jones D., et al. A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin. Aliment Pharmacol Ther 16 (2002) 699-705
33. Targan S.R., Feagan B.G., Fedorak R.N., Lashner B.A., Panaccione R., Present D.H., et al. Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial. Gastroenterology 132 (2007) 1672-1683
34. Feagan B.G., Greenberg G.R., Wild G., Fedorak R.N., Pare P., McDonald J.W., et al. Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin. N Engl J Med 352 (2005) 2499-2507